Dashboard

Sarepta Therapeutics, Inc. (SRPT)

Current

- (-)

After Hours

Rating & Fair Value

Fair Value Premium lock
Institutional Holdings

H

Financial Strength

H

Sustainable Growth

B

Industry Comparison

H

Management & Equity

B

Analyst Opinion

B

Leverage & Liquidity

B

Fundamental Variables

H

Rating Performance

FV Performance

*There is a current rating on the stock that is included in these numbers based on its performance so far

About

Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which is engaged in the discovery and development of therapeutics for the treatment of rare diseases. The company was founded on July 22, 1980 and is headquartered in Cambridge, MA.

CEO

Douglas S. Ingram

Employees

743

Industry

Neurology Biopharmaceuticals

Sector

Healthcare

Headquarters

Cambridge

Exchange

NASDAQ

Summary Stats

Market Cap

6.2B

Revenue

766M

Net Income

-357M

EPS

-$4.28

Price-to-Earnings

-16.57

Price-to-Book

7.24

Debt-to-Equity

2.57

News

Analyst Ratings

Price targets projected by 21 analysts

High

$217.00

Average

$188.38

Low

$140.00

Ratings calculated by 23 analysts

Buy

20

Hold

3

Sell

0

Last Dividend

Amount

-

Dividend Date

-

Frequency

-

Dividend Yield

Earnings

Most Recent Earnings

Last Earnings for Q1 2022

Last Earnings

Above by $0.71

Actual

-$0.56 +55.9%

Consensus

-1.27

Report Date

Year Ago

-1.54

Year Ago Change %

Up 63%

Actual vs Estimates

XX

xxx

Upcoming Estimates Unavailable

Expected EPS
-

-

Actual EPS
-

--

Competitors

star Favorites